Does LENALIDOMIDE Cause Gastrointestinal stromal tumour? 40 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Gastrointestinal stromal tumour have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.
40
Reports of Gastrointestinal stromal tumour with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
17
Deaths
27
Hospitalizations
How Dangerous Is Gastrointestinal stromal tumour From LENALIDOMIDE?
Of the 40 reports, 17 (42.5%) resulted in death, 27 (67.5%) required hospitalization, and 5 (12.5%) were considered life-threatening.
Is Gastrointestinal stromal tumour Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Gastrointestinal stromal tumour?
IMATINIB (899)
SUNITINIB MALATE (186)
RANITIDINE (184)
REGORAFENIB (108)
SUNITINIB (75)
GLIVEC (40)
VALSARTAN (35)
MYCOPHENOLATE MOFETIL (33)
NILOTINIB (33)
RITUXIMAB (33)
Which LENALIDOMIDE Alternatives Have Lower Gastrointestinal stromal tumour Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE